Novavax coronavirus vaccine produced higher levels of antibodies than seen in recovered patients
Novavax Inc announced its experimental vaccine produced a promising immune response against the novel coronavirus, according to early data from clinical trials. The Maryland-based company said participants generated high levels of neutralizing antibodies and T-cells, both of which are needed to build up immunity. What’s more, the levels were higher than those seen among patients … Read more